Amanta Healthcare Limited (NSE:AMANTA)

Market Cap	3.61B
Revenue (ttm)	2.83B -2.0%
Net Income	136.68M
EPS	4.17
Shares Out	34.34M
PE Ratio	25.21
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,247
Average Volume	39,011
Open	108.00
Previous Close	109.16
Day's Range	106.00 - 110.65
52-Week Range	97.75 - 154.40
Beta	n/a
RSI	48.18
Earnings Date	Feb 10, 2026

About Amanta Healthcare

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory ca...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 522
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMANTA

Financial Performance

In fiscal year 2025, Amanta Healthcare's revenue was 2.75 billion, a decrease of -2.01% compared to the previous year's 2.80 billion. Earnings were 105.01 million, an increase of 189.02%.